Quetiapine - Depression
You are here : Home > Formulary Search > Quetiapine - Depression
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Immediate release tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Preferred
Initiation and stabilisation by a SABP specialist for a minimum of 3 months before any request for transfer of prescribing responsibility.
Status 2
Red
Formulations :
- Modified release tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Modified release tablets are reserved for use when immediate release tablets are not suitable.
Modified release quetiapine MAY be continued in Primary Care (after a 3-month period of stabilisation by SABP) where the use of immediate release tablets would risk destabilising the patient.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Quetiapine
Indication :
Depression
Group Name :
Keywords :
major depression
Brand Names Include :
Important Information :
Adjunctive treatment of major depression.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Quetiapine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Depression.
Committee Recommendations (0)
- No records returned.